ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
1/1
0/0

Kinase Inhibitors Can Inhibit SARS-CoV-2 Mpro: A Theoretical Study

preprint
submitted on 26.08.2020 and posted on 26.08.2020 by BN Acharya
This study describes screening of DrugBank library for approved drugs by pharmacophore modeling and receptor-ligand docking. A 3D-QSAR model was generated on the
inhibition constants (Ki AutoDock ) determined by AutoDock. This 3D-QSAR model was statistically validated by Fischer’s randomization test and further evaluated by a test set
comprising 75 molecules. Ki AutoDock values of 49 molecules were predicted correctly by the 3D-QSAR model. The validated 3D-QSAR model was used for screening of DrugBank library for approved molecules to identify potential molecules against novel SARS corona virus-2 (SARS-CoV-2). Ten out of 40 the shortlisted molecules were kinase inhibitors.

Funding

NIL

History

Email Address of Submitting Author

bnacharya@yahoo.com

Institution

Defence R&D Establishment

Country

India

ORCID For Submitting Author

orcid.org/0000-0003-4946-5311

Declaration of Conflict of Interest

NIL

Exports

Logo branding

Exports